Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria Diaz"'
Autor:
Miran Blanchard, Kevin J. Harrington, Jill Thompson, Shane Zaidi, Richard G. Vile, Michael P. Grams, Rosa Maria Diaz, Kevin G. Shim, Kenneth R. Olivier, Keith M. Furutani, Hardev Pandha, Alan Melcher, Svetomir N. Markovic, Sean S. Park, Karishma Rajani
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:577-587
Purpose The oligometastatic state is an intermediate state between a malignancy that can be completely eradicated with conventional modalities and one in which a palliative approach is undertaken. Clinically, high rates of local tumor control are pos
Autor:
Diana Rommelfanger-Konkol, Peter Selby, Timothy Kottke, Elizabeth Ilett, Kevin J. Harrington, Karishma Rajani, Shane Zaidi, Hardev Pandha, Jose S. Pulido, O Donnelly, Alan Melcher, Richard G. Vile, Rosa Maria Diaz, Vanesa Alonso-Camino, Jill Thompson
Publikováno v:
Molecular Therapy. 22(11):1936-1948
Previously, we showed that vesicular stomatitis virus (VSV) engineered to express a cDNA library from human melanoma cells (ASMEL, Altered Self Melanoma Epitope Library) was an effective systemic therapy to treat subcutaneous (s.c.) murine B16 melano
Autor:
Scott E. Strome, Timothy Kottke, Phonphimon Wongthida, Candice Willmon, Feorillo Galivo, Richard G. Vile, Jose S. Pulido, John D. Chester, Alan Melcher, Kevin J. Harrington, Rosa Maria Diaz, Peter Selby, Karen M. Kaluza, Glen N. Barber, Jill Thompson
Publikováno v:
Molecular Therapy. 16(12):1910-1918
To protect viral particles from neutralization, sequestration, nonspecific adhesion, and mislocalization following systemic delivery, we have previously exploited the natural tumor-homing properties of antigen-specific CD8+ T cells. Thus, OT-I T cell
Autor:
Jill Thompson, Miran Blanchard, Michael P. Grams, Svetomir N. Markovic, Kevin G. Shim, Timothy Kottke, Richard G. Vile, Rosa Maria Diaz, Shane Zaidi
Publikováno v:
Molecular Therapy. 23:S165-S166
Oligometastatic (OM) disease represents an intermediate stage of progression between fully systemic metastasized disease and localized tumor burden. Clinical data is emerging that patients with OM are potentially curable, in part because of advances
Autor:
Rosa Maria Diaz, Uma Thanarajasingam, Richard G. Vile, Michael J. Gough, Laura Sanz, Jill Thompson
Publikováno v:
Molecular Therapy. 11:S312
In order to generate antitumor immunity through direct in situ modification of an established primary tumor, it will be necessary to recruit antigen presenting cells to the tumor site, release tumor antigens in an immunostimulatory, rather than toler